Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Selling, General & Administrative (2009 - 2026)

Updated

Vistagen Therapeutics (VTGN) reported Selling, General & Administrative of $4.52 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 2.8% from $4.4 million a year earlier and up 15.4% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Selling, General & Administrative (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Vistagen Therapeutics' Selling, General & Administrative came in at $18.19 million, up 6.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $18.42 million, up 7.8% from FY2025.

  • Selling, General & Administrative has a five-year compound annual growth rate of 21.0% (FY2021 to FY2026).
  • By fiscal year, Selling, General & Administrative came in at $17.08 million in FY2025 (+21.5%), $14.06 million in FY2024 (-4.1%), $14.66 million in FY2023 (+8.8%) and $13.48 million in FY2022 (+89.9%).
  • Five-year quarterly Selling, General & Administrative spans a low of $2.98 million in fiscal Q1 2024 and a high of $5.63 million in fiscal Q3 2026.
  • Year over year, Selling, General & Administrative gained in five of the last eight quarters, with growth averaging 5.0%.
  • The high point for year-over-year Selling, General & Administrative in five years was fiscal Q4 2022 (growth of 154.1%); the low point was fiscal Q1 2024 (a decline of 37.9%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $3.92 million (Q1 2027), $4.12 million (Q4 2026) and $5.63 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 921,321.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 3.13 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 6.29 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 4.09 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 2.89 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 1.64 Bn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 4.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.52 Mn
Jun 30, 2026 3.92 Mn
Mar 31, 2026 4.12 Mn
Dec 31, 2025 5.63 Mn
Sep 30, 2025 4.40 Mn
Jun 30, 2025 4.37 Mn
Mar 31, 2025 4.27 Mn
Dec 31, 2024 4.05 Mn
Sep 30, 2024 4.20 Mn
Jun 30, 2024 4.57 Mn
Mar 31, 2024 4.12 Mn
Dec 31, 2023 3.76 Mn
Sep 30, 2023 3.21 Mn
Jun 30, 2023 2.98 Mn
Mar 31, 2023 3.08 Mn
Dec 31, 2022 3.09 Mn
Sep 30, 2022 3.70 Mn
Jun 30, 2022 4.79 Mn
Mar 31, 2022 4.50 Mn
Dec 31, 2021 3.12 Mn
API Access

Vistagen Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VTGN&period=max&api_key=YOUR_API_KEY